HIGHLAND CAPITAL MANAGEMENT LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$223,000
-14.2%
2,100
-51.7%
0.01%
-8.3%
Q4 2017$260,000
-5.8%
4,350
-62.2%
0.01%0.0%
Q3 2017$276,000
-43.6%
11,500
-54.0%
0.01%
-42.9%
Q2 2017$489,000
-16.7%
25,0000.0%0.02%
-30.0%
Q1 2017$587,000
-52.2%
25,000
-75.0%
0.03%
-48.3%
Q4 2016$1,227,000100,0000.06%
Q3 2013$000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders